Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer.
Ajani JA, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru DM, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG. Ajani JA, et al. Among authors: taketa t. Ann Oncol. 2012 Oct;23(10):2638-2642. doi: 10.1093/annonc/mds210. Epub 2012 Jul 24. Ann Oncol. 2012. PMID: 22831985 Free PMC article.
Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort.
Cheedella NK, Suzuki A, Xiao L, Hofstetter WL, Maru DM, Taketa T, Sudo K, Blum MA, Lin SH, Welch J, Lee JH, Bhutani MS, Rice DC, Vaporciyan AA, Swisher SG, Ajani JA. Cheedella NK, et al. Among authors: taketa t. Ann Oncol. 2013 May;24(5):1262-6. doi: 10.1093/annonc/mds617. Epub 2012 Dec 17. Ann Oncol. 2013. PMID: 23247658 Free PMC article.
A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer.
Ajani JA, Xiao L, Roth JA, Hofstetter WL, Walsh G, Komaki R, Liao Z, Rice DC, Vaporciyan AA, Maru DM, Lee JH, Bhutani MS, Eid A, Yao JC, Phan AP, Halpin A, Suzuki A, Taketa T, Thall PF, Swisher SG. Ajani JA, et al. Among authors: taketa t. Ann Oncol. 2013 Nov;24(11):2844-9. doi: 10.1093/annonc/mdt339. Epub 2013 Aug 23. Ann Oncol. 2013. PMID: 23975663 Free PMC article. Clinical Trial.
Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation.
Suzuki A, Xiao L, Taketa T, Sudo K, Wadhwa R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmus J, Swisher SG, Hofstetter WL, Ajani JA. Suzuki A, et al. Among authors: taketa t. Ann Oncol. 2013 Nov;24(11):2854-9. doi: 10.1093/annonc/mdt340. Epub 2013 Aug 29. Ann Oncol. 2013. PMID: 23994746 Free article.
ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients.
Ajani JA, Wang X, Song S, Suzuki A, Taketa T, Sudo K, Wadhwa R, Hofstetter WL, Komaki R, Maru DM, Lee JH, Bhutani MS, Weston B, Baladandayuthapani V, Yao Y, Honjo S, Scott AW, Skinner HD, Johnson RL, Berry D. Ajani JA, et al. Among authors: taketa t. Mol Oncol. 2014 Feb;8(1):142-9. doi: 10.1016/j.molonc.2013.10.007. Epub 2013 Oct 28. Mol Oncol. 2014. PMID: 24210755 Free PMC article.
Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillance.
Wadhwa R, Taketa T, Correa AM, Sudo K, Campagna MC, Blum MA, Komaki R, Skinner H, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Wadhwa R, et al. Among authors: taketa t. Oncology. 2013;85(4):204-7. doi: 10.1159/000354736. Epub 2013 Sep 19. Oncology. 2013. PMID: 24051869
Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies.
Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Skinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Sudo K, et al. Among authors: taketa t. J Clin Oncol. 2013 Dec 1;31(34):4306-10. doi: 10.1200/JCO.2013.51.7250. Epub 2013 Oct 21. J Clin Oncol. 2013. PMID: 24145339 Free PMC article.
Chemoradiation for esophageal cancer.
Blum MA, Taketa T, Sudo K, Wadhwa R, Skinner HD, Ajani JA. Blum MA, et al. Among authors: taketa t. Thorac Surg Clin. 2013 Nov;23(4):551-8. doi: 10.1016/j.thorsurg.2013.07.006. Thorac Surg Clin. 2013. PMID: 24199704 Review.
Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma.
Taketa T, Sudo K, Correa AM, Wadhwa R, Shiozaki H, Elimova E, Campagna MC, Blum MA, Skinner HD, Komaki RU, Lee JH, Bhutani MS, Weston BR, Rice DC, Swisher SG, Maru DM, Hofstetter WL, Ajani JA. Taketa T, et al. J Natl Compr Canc Netw. 2014 Aug;12(8):1139-44. doi: 10.6004/jnccn.2014.0111. J Natl Compr Canc Netw. 2014. PMID: 25099446
57 results